Green Process Chemistry

OUR STRATEGY

​

Our strategy is to leverage our expertise in organocatalysis to design and develop robust, scalable, green processes to make advanced intermediates, API’s and other high-value compounds.  
 

Our suite of in-house organocatalysts are cheap, selective, scalable and recyclable; and do not use expensive precious metals.

​​

Typical process characteristics include:

• High yields

• No temperature or pressure extremes required

• All solvents class 2 or 3

• E-factor of between 10 and 15

​​

OUR SUCCESS

​

Notable successes include our processes for advanced intermediates of the following drugs – typically yielding a 60-80% reduction in Raw Material Costs:

• Pregabalin

• Atomoxetine

• Duloxetine

• Montelukast

​

We also actively engage on projects with Pharmaceutical and Fine Chemical partners to develop next-generation processes for high-value intermediates.

​

Please contact us with any queries.